UK-based Mercia Fund Management has agreed to invest 230,000 pounds in Aston EyeTech, an Aston University spin-out. Aston EyeTech is a provider of software that helps optometrists with diagnosis, selling optical products and conducting clinical trials.
Henley-in-Arden, UK, 1 September 2014. Technology investor Mercia Fund Management today announced its first investment in an Aston University spin-out, Aston EyeTech Limited.
Aston EyeTech has developed software that supports optometrists with diagnosis, selling optical products and conducting clinical trials. Mercia Fund Management has agreed to invest £230,000 in the first instance.
The funding will be used to grow the team and other resources required in year one as the company builds and trials the initial product range.
A spin-out from Aston University’s School of Optometry, an international leader in optometry research and professional training, Aston EyeTech is targeting optical retailers in the UK and overseas, clinical trials organisations, domiciliary service providers and the NHS.
Aston EyeTech will help opticians make more accurate and consistent diagnoses of eye conditions, ensuring that high professional standards are met and that medico-legal protection is strengthened. It will help opticians sell more items through greater personalisation of product recommendations. For clinical trials, Aston EyeTech’s software enables eye tests to be conducted more efficiently, with faster collation and analysis of results.
The software uses mathematical techniques never previously deployed in the field of optometry, and is already being considered by a major player in the optometry sector who will host product trials and collaborate on development.
Paul Blackburn, Executive Chairman of Aston EyeTech commented on working with Mercia: “The Mercia team has been excellent at pulling together phase one financing and in dealing with the complexities of the university’s involvement as a founder shareholder, including their licensing of intellectual property.”
Senior Investment Director at Mercia Fund Management, Tim Hazell, comments: “Mercia already has a strong track record of investing in university spin-outs and we are delighted to add an Aston University start-up to our portfolio. This investment will enable Aston EyeTech to make major steps in the commercialisation of its unique software in an established and highly receptive market. The company is yet another example of the high quality businesses that Mercia has backed with its university partners.”
About Mercia Fund Management
Mercia Fund Management is a Midland’s based investment business investing nationally with over £22 million and growing under active management.
Mercia Fund Management provides investment growth capital for technology-backed businesses ranging from early commercial traction through to those seeking expansion or working capital that are trading profitably. Furthermore, Mercia Fund Management can also provide cost-effective post-seed incubator accommodation at its modern facility at the Forward House Workspace in Henley-in-Arden for established portfolio companies, as well as early stage non-portfolio companies, looking for a supportive dynamic environment on offer from an incumbent investment manager who can also provide centralised support services.
Mercia Fund Management is an FCA authorised and regulated fund manager under FSMA (FRN: 524856).